Actively Recruiting

Age: 18Years +
MALE
NCT06039085

Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment

Led by Ryan J. Halter · Updated on 2026-04-07

200

Participants Needed

1

Research Sites

217 weeks

Total Duration

On this page

Sponsors

R

Ryan J. Halter

Lead Sponsor

D

Dartmouth College

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research will study a custom device developed to detect if any prostate cancer tissue is left behind when the prostate is removed. This device is called an Electrical Impedance Imaging (EII) probe.

CONDITIONS

Official Title

Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical diagnosis of prostate cancer requiring RARP
  • Ability to understand and willingness to sign a written informed consent document
  • Age 18 years or older
Not Eligible

You will not qualify if you...

  • Adults with implanted electrical devices such as pacemakers
  • Prisoners
  • Adults with impaired decision-making capacity
  • Any condition that contraindicates study participation as judged by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States, 03756

Actively Recruiting

Loading map...

Research Team

R

Ryan J Halter, PhD

CONTACT

K

Kathy J Phipps, BA

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment | DecenTrialz